source
- Report highlights 20 women reshaping biopharma across oncology and rare disease fieldsThe 2026 special report spotlights twenty women who are driving change in biopharma, covering areas such as oncology and rare diseases. The series, now in its eighth year, has recognized over 160…
- Eli Lilly reports strongest weight-loss data yet; Sanofi and Regeneron secure $1 billion upfront dealThe weekly Endpoints newsletter dated October 3, 2026 highlights that Eli Lilly's latest weight‑loss trial produced its best‑ever results. While the article does not provide specific numbers, the…